Literature DB >> 836052

Natural history of Hartnup disease.

B Wilcken, J S Yu, D A Brown.   

Abstract

Hartnup disease was diagnosed in 12 children and 3 of their 15 sibs in the course of routine urine screening of 6-week-old infants in New South Wales. These children were followed for up to 8 years, during which time there were only two clinical episodes which might be ascribed to Hartnup disease. The mental development of all the children was normal. 10 had height centiles less than the midparent height centiles, while 4 had centiles equal to or above the midparent centiles. The study shows that in children with Hartnup disease in Australia symptoms are very uncommon. Mental development is normal, and heights are possibly slightly below that expected. Hartnup disease has an incidence of approximately 1 in 33 000 in New South Wales.

Entities:  

Mesh:

Year:  1977        PMID: 836052      PMCID: PMC1546217          DOI: 10.1136/adc.52.1.38

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Stature and nutrition in cystinuria and Hartnup disease.

Authors:  J E COLLISS; A J LEVI; M D MILNE
Journal:  Br Med J       Date:  1963-03-02

2.  Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria, and other bizarre biochemical features.

Authors:  D N BARON; C E DENT; H HARRIS; E W HART; J B JEPSON
Journal:  Lancet       Date:  1956-09-01       Impact factor: 79.321

3.  Frequency of inborn errors of metabolism, especially PKU, in some representative newborn screening centers around the world: a collaborative study.

Authors: 
Journal:  Humangenetik       Date:  1975-12-23

4.  Screening for metabolic diseases in New South Wales.

Authors:  B Wilcken; A Smith; T J Gaha; A C McLeay; D A Brown
Journal:  Med J Aust       Date:  1973-06-09       Impact factor: 7.738

5.  Aminoacid excretion in infancy and early childhood. A survey of 100,000 infants.

Authors:  B Turner; D A Brown
Journal:  Med J Aust       Date:  1970-01-03       Impact factor: 7.738

6.  Standards for children's height at ages 2-9 years allowing for heights of parents.

Authors:  J M Tanner; H Goldstein; R H Whitehouse
Journal:  Arch Dis Child       Date:  1970-12       Impact factor: 3.791

  6 in total
  13 in total

1.  Hartnup disorder: polymorphisms identified in the neutral amino acid transporter SLC1A5.

Authors:  S J Potter; A Lu; B Wilcken; K Green; J E J Rasko
Journal:  J Inherit Metab Dis       Date:  2002-10       Impact factor: 4.982

Review 2.  Metabolic syndromes with dermatologic manifestations.

Authors:  M Irons; H L Levy
Journal:  Clin Rev Allergy       Date:  1986-02

3.  The Hartnup phenotype: Mendelian transport disorder, multifactorial disease.

Authors:  C R Scriver; B Mahon; H L Levy; C L Clow; T M Reade; J Kronick; B Lemieux; C Laberge
Journal:  Am J Hum Genet       Date:  1987-05       Impact factor: 11.025

4.  Circumvention of defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester.

Authors:  A J Jonas; I J Butler
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  A candidate mouse model for Hartnup disorder deficient in neutral amino acid transport.

Authors:  D J Symula; A Shedlovsky; E N Guillery; W F Dove
Journal:  Mamm Genome       Date:  1997-02       Impact factor: 2.957

6.  An electrochemical aptamer-based sensor for the rapid and convenient measurement of L-tryptophan.

Authors:  Andrea Idili; Julian Gerson; Claudio Parolo; Tod Kippin; Kevin W Plaxco
Journal:  Anal Bioanal Chem       Date:  2019-02-22       Impact factor: 4.142

Review 7.  The molecular basis of neutral aminoacidurias.

Authors:  Angelika Bröer; Juleen A Cavanaugh; John E J Rasko; Stefan Bröer
Journal:  Pflugers Arch       Date:  2005-07-29       Impact factor: 3.657

8.  Hartnup disease masked by kwashiorkor.

Authors:  Zerrin Orbak; Vildan Ertekin; Ayse Selimoglu; Nebahat Yilmaz; Huseyin Tan; Murat Konak
Journal:  J Health Popul Nutr       Date:  2010-08       Impact factor: 2.000

9.  Inhibiting neutral amino acid transport for the treatment of phenylketonuria.

Authors:  Adam M Belanger; Malgorzata Przybylska; Estelle Gefteas; Matthew Furgerson; Sarah Geller; Alla Kloss; Seng H Cheng; Yunxiang Zhu; Nelson S Yew
Journal:  JCI Insight       Date:  2018-07-26

10.  A Brief Historic Overview of Clinical Disorders Associated with Tryptophan: The Relevance to Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM).

Authors:  Adele Blankfield
Journal:  Int J Tryptophan Res       Date:  2012-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.